Neuroprotective ferulic acid (FA)-glycol chitosan (GC) nanoparticles for functional restoration of traumatically injured spinal cord

Wei Wu, Seung Young Lee, Xiangbing Wu, Jacqueline Y. Tyler, He Wang, Zheng Ouyang, Kinam Park, Xiao-Ming Xu, Ji Xin Cheng

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

An urgent unmet need exists for early-stage treatment of spinal cord injury (SCI). Currently methylprednisolone is the only therapeutic agent used in clinics, for which the efficacy is controversial and the side effect is well-known. We demonstrated functional restoration of injured spinal cord by self-assembled nanoparticles composed of ferulic acid modified glycol chitosan (FA-GC). Chitosan and ferulic acid are strong neuroprotective agents but their systemic delivery is difficult. Our data has shown a prolonged circulation time of the FA-GC nanoparticles allowing for effective delivery of both chitosan and ferulic acid to the injured site. Furthermore, the nanoparticles were found both in the gray matter and white matter. The invitro tests demonstrated that nanoparticles protected primary neurons from glutamate-induced excitotoxicity. Using a spinal cord contusion injury model, significant recovery in locomotor function was observed in rats that were intravenously administered nanoparticles at 2h post injury, as compared to non-improvement by methylprednisolone administration. Histological analysis revealed that FA-GC treatment significantly preserved axons and myelin and also reduced cavity volume, astrogliosis, and inflammatory response at the lesion site. No obvious adverse effects of nanoparticles to other organs were found. The restorative effect of FA-GC presents a promising potential for treating human SCIs.

Original languageEnglish
Pages (from-to)2355-2364
Number of pages10
JournalBiomaterials
Volume35
Issue number7
DOIs
StatePublished - Feb 2014

Fingerprint

ferulic acid
Glycols
Chitosan
Nanoparticles
Restoration
Spinal Cord
Acids
Spinal Cord Injuries
Methylprednisolone
Neuroprotective Agents
Myelin Sheath
Neurons
Axons
glycol-chitosan
Rats
Glutamic Acid

Keywords

  • Anti-excitotoxicity
  • Ferulic acid
  • Functional restoration
  • Glycol chitosan
  • Neuroprotective polymer
  • Spinal cord injury

ASJC Scopus subject areas

  • Biomaterials
  • Bioengineering
  • Ceramics and Composites
  • Mechanics of Materials
  • Biophysics

Cite this

Neuroprotective ferulic acid (FA)-glycol chitosan (GC) nanoparticles for functional restoration of traumatically injured spinal cord. / Wu, Wei; Lee, Seung Young; Wu, Xiangbing; Tyler, Jacqueline Y.; Wang, He; Ouyang, Zheng; Park, Kinam; Xu, Xiao-Ming; Cheng, Ji Xin.

In: Biomaterials, Vol. 35, No. 7, 02.2014, p. 2355-2364.

Research output: Contribution to journalArticle

Wu, Wei ; Lee, Seung Young ; Wu, Xiangbing ; Tyler, Jacqueline Y. ; Wang, He ; Ouyang, Zheng ; Park, Kinam ; Xu, Xiao-Ming ; Cheng, Ji Xin. / Neuroprotective ferulic acid (FA)-glycol chitosan (GC) nanoparticles for functional restoration of traumatically injured spinal cord. In: Biomaterials. 2014 ; Vol. 35, No. 7. pp. 2355-2364.
@article{db9e485e88114e4b998159b3c27e7772,
title = "Neuroprotective ferulic acid (FA)-glycol chitosan (GC) nanoparticles for functional restoration of traumatically injured spinal cord",
abstract = "An urgent unmet need exists for early-stage treatment of spinal cord injury (SCI). Currently methylprednisolone is the only therapeutic agent used in clinics, for which the efficacy is controversial and the side effect is well-known. We demonstrated functional restoration of injured spinal cord by self-assembled nanoparticles composed of ferulic acid modified glycol chitosan (FA-GC). Chitosan and ferulic acid are strong neuroprotective agents but their systemic delivery is difficult. Our data has shown a prolonged circulation time of the FA-GC nanoparticles allowing for effective delivery of both chitosan and ferulic acid to the injured site. Furthermore, the nanoparticles were found both in the gray matter and white matter. The invitro tests demonstrated that nanoparticles protected primary neurons from glutamate-induced excitotoxicity. Using a spinal cord contusion injury model, significant recovery in locomotor function was observed in rats that were intravenously administered nanoparticles at 2h post injury, as compared to non-improvement by methylprednisolone administration. Histological analysis revealed that FA-GC treatment significantly preserved axons and myelin and also reduced cavity volume, astrogliosis, and inflammatory response at the lesion site. No obvious adverse effects of nanoparticles to other organs were found. The restorative effect of FA-GC presents a promising potential for treating human SCIs.",
keywords = "Anti-excitotoxicity, Ferulic acid, Functional restoration, Glycol chitosan, Neuroprotective polymer, Spinal cord injury",
author = "Wei Wu and Lee, {Seung Young} and Xiangbing Wu and Tyler, {Jacqueline Y.} and He Wang and Zheng Ouyang and Kinam Park and Xiao-Ming Xu and Cheng, {Ji Xin}",
year = "2014",
month = "2",
doi = "10.1016/j.biomaterials.2013.11.074",
language = "English",
volume = "35",
pages = "2355--2364",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",
number = "7",

}

TY - JOUR

T1 - Neuroprotective ferulic acid (FA)-glycol chitosan (GC) nanoparticles for functional restoration of traumatically injured spinal cord

AU - Wu, Wei

AU - Lee, Seung Young

AU - Wu, Xiangbing

AU - Tyler, Jacqueline Y.

AU - Wang, He

AU - Ouyang, Zheng

AU - Park, Kinam

AU - Xu, Xiao-Ming

AU - Cheng, Ji Xin

PY - 2014/2

Y1 - 2014/2

N2 - An urgent unmet need exists for early-stage treatment of spinal cord injury (SCI). Currently methylprednisolone is the only therapeutic agent used in clinics, for which the efficacy is controversial and the side effect is well-known. We demonstrated functional restoration of injured spinal cord by self-assembled nanoparticles composed of ferulic acid modified glycol chitosan (FA-GC). Chitosan and ferulic acid are strong neuroprotective agents but their systemic delivery is difficult. Our data has shown a prolonged circulation time of the FA-GC nanoparticles allowing for effective delivery of both chitosan and ferulic acid to the injured site. Furthermore, the nanoparticles were found both in the gray matter and white matter. The invitro tests demonstrated that nanoparticles protected primary neurons from glutamate-induced excitotoxicity. Using a spinal cord contusion injury model, significant recovery in locomotor function was observed in rats that were intravenously administered nanoparticles at 2h post injury, as compared to non-improvement by methylprednisolone administration. Histological analysis revealed that FA-GC treatment significantly preserved axons and myelin and also reduced cavity volume, astrogliosis, and inflammatory response at the lesion site. No obvious adverse effects of nanoparticles to other organs were found. The restorative effect of FA-GC presents a promising potential for treating human SCIs.

AB - An urgent unmet need exists for early-stage treatment of spinal cord injury (SCI). Currently methylprednisolone is the only therapeutic agent used in clinics, for which the efficacy is controversial and the side effect is well-known. We demonstrated functional restoration of injured spinal cord by self-assembled nanoparticles composed of ferulic acid modified glycol chitosan (FA-GC). Chitosan and ferulic acid are strong neuroprotective agents but their systemic delivery is difficult. Our data has shown a prolonged circulation time of the FA-GC nanoparticles allowing for effective delivery of both chitosan and ferulic acid to the injured site. Furthermore, the nanoparticles were found both in the gray matter and white matter. The invitro tests demonstrated that nanoparticles protected primary neurons from glutamate-induced excitotoxicity. Using a spinal cord contusion injury model, significant recovery in locomotor function was observed in rats that were intravenously administered nanoparticles at 2h post injury, as compared to non-improvement by methylprednisolone administration. Histological analysis revealed that FA-GC treatment significantly preserved axons and myelin and also reduced cavity volume, astrogliosis, and inflammatory response at the lesion site. No obvious adverse effects of nanoparticles to other organs were found. The restorative effect of FA-GC presents a promising potential for treating human SCIs.

KW - Anti-excitotoxicity

KW - Ferulic acid

KW - Functional restoration

KW - Glycol chitosan

KW - Neuroprotective polymer

KW - Spinal cord injury

UR - http://www.scopus.com/inward/record.url?scp=84891372059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891372059&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2013.11.074

DO - 10.1016/j.biomaterials.2013.11.074

M3 - Article

C2 - 24332460

AN - SCOPUS:84891372059

VL - 35

SP - 2355

EP - 2364

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 7

ER -